Our health technology assessment institution is not into unconditional surrenders. It habitually buys time to consolidate its position with the goal of revisiting the issue. On the issue of multiple sclerosis medicines, this is what victory looks like in a single-payer system. …
It doesn't always feel like it, but make no mistake, this is what winning looks like
July 17, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Injunction blocks generic launch of key HIV combination medicine
August 6, 2026 - - Latest News -
Moderna begins Phase 1 trial of vaccine candidate against Bundibugyo Ebola Virus
August 6, 2026 - - Latest News -
Neuren reports record DAYBUE sales as royalties rise and global expansion nears
August 6, 2026 - - Australian Biotech -
NSW urged to think pharmacy first as 250 pharmacists near completion of advanced training
August 6, 2026 - - Latest News -
If Australian companies shun their domestic market, who can blame multinationals?
August 6, 2026 - - Latest News -
The complete absence of patient power and agency makes this a health system outlier
August 4, 2026 - - Latest News -
Pharmac announces plan to revise its recently expanded patient advisory function
August 4, 2026 - - Latest News